Search results
Results from the WOW.Com Content Network
Glucocorticoid remediable aldosteronism. Glucocorticoid remediable aldosteronism also describable as aldosterone synthase hyperactivity, is an autosomal dominant disorder in which the increase in aldosterone secretion produced by ACTH is no longer transient. It is a cause of primary hyperaldosteronism. [1]
t. e. Gastroesophageal reflux disease ( GERD) or gastro-oesophageal reflux disease ( GORD) is a chronic upper gastrointestinal disease in which stomach content persistently and regularly flows up into the esophagus, resulting in symptoms and/or complications. [6] [7] [10] Symptoms include dental corrosion, dysphagia, heartburn, odynophagia ...
Mast cell activation syndrome (MCAS) is a term referring to one of two types of mast cell activation disorder (MCAD); the other type is idiopathic MCAD. MCAS is an immunological condition in which mast cells inappropriately and excessively release chemical mediators, resulting in a range of chronic symptoms, sometimes including anaphylaxis or near-anaphylaxis attacks.
Treatment. Treating hypermobility syndrome can be difficult. The condition has no direct cure, but its symptoms can be treated. Physiotherapy, particularly exercise, is the main treatment for the condition, although there is only limited evidence for its effectiveness. Treatments for pain include: Bandaging the affected area;
Posterior reversible encephalopathy syndrome ( PRES ), also known as reversible posterior leukoencephalopathy syndrome ( RPLS ), is a rare condition in which parts of the brain are affected by swelling, usually as a result of an underlying cause. Someone with PRES may experience headaches, changes in vision, and seizures, with some developing ...
ACDC (medicine) Arterial calcification due to deficiency of CD73 (ACDC) is a rare genetic disorder that causes calcium buildup in the arteries and joints of the hands and feet, and other areas below the waist. [1] Although patients exhibiting these symptoms have been identified as early as 1914, this disorder had not been studied extensively ...
Glutathione synthetase deficiency (GSD) is a rare autosomal recessive metabolic disorder that prevents the production of glutathione.Glutathione helps prevent damage to cells by neutralizing harmful molecules generated during energy production.
Treatment. There are several treatments available for factor VII deficiency; they all replace deficient FVII. Recombinant FVIIa concentrate (rFVIIa) is a recombinant treatment that is highly effective and has no risk of fluid overload or viral disease. It may be the optimal therapy.